MedPath

use of shiva guugul and virechan in rheumatic arthritis

Not Applicable
Completed
Conditions
Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor
Registration Number
CTRI/2021/12/038439
Lead Sponsor
PtKhushilal Sharma Govt Autonomus College and Institute Bhopal MP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

.Age between 35 ââ?¬â?? 65 years of either sex.

.Patients fulfilling the American college of Rheumatology 2010 revised criterias of RA. .Patients willing to sign written consent form for participation in the study.

Exclusion Criteria

1. Age below 35 and above 65 years.

2. Patients who develop secondary complication of RA e.g. Pleuro-pericardial disease, severely damagedjoint with bed ridden patients.

3. Any other serious illness e.g. Hepatic/ renal failure.

4. Patient with diagnosed other arthritis like Gouty arthritis, tuberculosis arthritis etc.

5. Patient receiving any other method of treatment.

6. Patients having severe crippling deformities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that at the end of the study , we would be able to demonstrate and explain the efficacy of Shiva guggulu along with Virechan Karma in the management of Aamvat (RA).Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
It is expected that at the end of the study , we would be able to demonstrate and explain the efficacy of Shiva guggulu along with Virechan Karma in the management of Aamvat (RA).Timepoint: 11 months
© Copyright 2025. All Rights Reserved by MedPath